The assessment of the immunogenicity of different batches of live L-16 measles vaccine in urban and rural localities
Ninashvili, N.Z.; Gelikman, B.G.; Shavdiia, N.T.; Elikashvili, M.I.; Gogokhia, T.N.
Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 72-74
1993
ISSN/ISBN: 0372-9311 PMID: 8079578 Document Number: 411481
Document emailed within 1 workday
Related Documents
Makino, S.; Sasaki, K.; Nakamura, N.; Nakagawa, M.; Nakajima, S. 1974: Studies on the modification of the live AIK measles vaccine. II. Development and evaluation of the live AIK-C measles vaccine Kitasato Archives of Experimental Medicine 47(1-2): 13-21André, F.E.; Peetermans, J. 1986: Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine Developments in Biological Standardization 65: 101-107
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
Domorázková, E.; Drevo, M.; Burian, V.; Burianová-Vysoká, B.; Janotová, J.; Kratochvílová, M.; Kríz, J.; Vodicková, M.; Kyselová, M. 1973: Use of live measles vaccine in the 3d injection of basic DTPA vaccine (Diphtheria, Tetanus, Pertussia Antitoxin) Ceskoslovenska Pediatrie 28(3): 129-130
Gatchalian, S.; Tabora, C.; Bermal, N.; Leboulleux, D.; Desauziers, E. 2004: Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old American Journal of Tropical Medicine and Hygiene 70(3): 273-277
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Parmar, V.R.; Sood, A.K.; Goyal, A.; Sharma, V.; Singh, T. 1996: Immunogenicity of Edmonston-Zagreb measles vaccine Indian Pediatrics 33(10): 845-850
Popov, V.F.; Ivannikov, I.G.; Luk'ianov, I.V. 1972: The economic effectiveness of using live measles vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 49(8): 37-39
Simasathien, S.; Thomas, S.J.; Watanaveeradej, V.; Nisalak, A.; Barberousse, Célia.; Innis, B.L.; Sun, W.; Putnak, J.Robert.; Eckels, K.H.; Hutagalung, Y.; Gibbons, R.V.; Zhang, C.; De La Barrera, R.; Jarman, R.G.; Chawachalasai, W.; Mammen, M.P. 2008: Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children American Journal of Tropical Medicine and Hygiene 78(3): 426-433
Popov, V.F.; Parkhomov, I.I.; Semen'kova, L.I. 1973: Postvaccinal immunity in those inoculated with live measles vaccine Voprosy Virusologii 18(4): 455-458
Schumacher, H.; Welbers de Liddle, I.B. 1971: Antibody titres three years after immunization with a live measles vaccine German Medical Monthly 1(1): 37-41
Vasil'eva, G.A.; Slatin, E.A. 1983: Inoculation properties of live combined vaccine against measles and mumps Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 70-75
Vasil'eva, N.A.; Kashuba, V.N. 1982: Economic effectiveness of using a live measles vaccine in an agricultural area of the Ukrainian SSR Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 57-60
Rogers, S.; Sanders, R.C.; Alpers, M.P. 1991: Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua new Guinean children from four months of age Journal of Tropical Medicine and Hygiene 94(2): 88-91
Ristori, C.; Boccardo, H.; Borgoño, J.M.; Greiber, R.; Heras, E.; Carrillo, B.; Solari, G.; Concha, F. 1970: Clinical and serological studies with a live further attenuated measles vaccine (Moraten) in Chile Revista Medica de Chile 98(1): 42-45
Gatchalian, S.; Cordero-Yap, L.; Lu-Fong, M.; Soriano, R.; Ludan, A.; Chitour, K.; Bock, H.L. 1999: A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age Southeast Asian Journal of Tropical Medicine and Public Health 30(3): 511-517
Groome, M.J.; Moon, S-Sil.; Velasquez, D.; Jones, S.; Koen, A.; van Niekerk, N.; Jiang, B.; Parashar, U.D.; Madhi, S.A. 2014: Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa Bulletin of the World Health Organization 92(4): 238-245
He, H.; Chen, E.; Chen, H.; Wang, Z.; Li, Q.; Yan, R.; Guo, J.; Zhou, Y.; Pan, J.; Xie, S. 2014: Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children Vaccine 32(31): 4001-4005
Fowlkes, A.; Witte, D.; Beeler, J.; Audet, S.; Garcia, P.; Curns, A.; Yang, C.; Fudzulani, R.; Broadhead, R.; Bellini, W.J.; Cutts, F.; Helfand, R.F. 2011: Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi Journal of Infectious Diseases 204(Suppl 1): S149-S157